{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T20:22:33Z","timestamp":1785788553137,"version":"3.56.0"},"reference-count":133,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100008238","name":"Hebei Provincial Department of Science and Technology","doi-asserted-by":"publisher","award":["22567607\\u2009H"],"award-info":[{"award-number":["22567607\\u2009H"]}],"id":[{"id":"10.13039\/501100008238","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003787","name":"Natural Science Foundation of Hebei Province","doi-asserted-by":"publisher","award":["H2024208010"],"award-info":[{"award-number":["H2024208010"]}],"id":[{"id":"10.13039\/501100003787","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Colloids and Surfaces B: Biointerfaces"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.colsurfb.2026.115842","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T23:35:48Z","timestamp":1779492948000},"page":"115842","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Oral liver-targeted delivery systems for anti-hyperglycemic therapy: From passive to active targeting strategies"],"prefix":"10.1016","volume":"266","author":[{"given":"Yahui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanping","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiayi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunlei","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengge","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zibin","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijia","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7479","key":"10.1016\/j.colsurfb.2026.115842_bib1","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/504198a","article-title":"Diabetes drugs ride a bumpy road","volume":"504","author":"Ledford","year":"2013","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.colsurfb.2026.115842_bib2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00011-019-01220-4","article-title":"The influence of ICAM1 rs5498 on diabetes mellitus risk: evidence from a meta-analysis","volume":"68","author":"Mi","year":"2019","journal-title":"Inflamm. Res."},{"issue":"4","key":"10.1016\/j.colsurfb.2026.115842_bib3","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1007\/s12264-024-01342-8","article-title":"Type 2 Diabetes Mellitus Exacerbates Pathological Processes of Parkinson's Disease: Insights from Signaling Pathways Mediated by Insulin Receptors","volume":"41","author":"Liu","year":"2025","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.colsurfb.2026.115842_bib4","doi-asserted-by":"crossref","unstructured":"2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2021, Diabetes care 44 (Suppl 1) (2021) S15\u2013S33.","DOI":"10.2337\/dc21-S002"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115842_bib5","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/s41574-024-01029-0","article-title":"Harnessing cellular therapeutics for type 1 diabetes mellitus: progress, challenges, and the road ahead","volume":"21","author":"Grattoni","year":"2025","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.colsurfb.2026.115842_bib6","article-title":"Suspension of basal insulin to avoid hypoglycemia in type 1 diabetes treated with insulin pump, Endocrinology","volume":"2015","author":"Boronat","year":"2015","journal-title":"Diabetes & Metab. case Rep."},{"issue":"13","key":"10.1016\/j.colsurfb.2026.115842_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310927","article-title":"A receptor story: insulin resistance pathophysiology and physiologic insulin resensitization's role as a treatment modality","volume":"24","author":"Lewis","year":"2023","journal-title":"Int J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.colsurfb.2026.115842_bib8","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126974","article-title":"Targeting insulin to the liver corrects defects in glucose metabolism caused by peripheral insulin delivery","volume":"5","author":"Edgerton","year":"2019","journal-title":"JCI Insight"},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115842_bib9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1507\/endocrj.EJ24-0192","article-title":"Physiological and pathophysiological actions of insulin in the liver","volume":"72","author":"Kubota","year":"2025","journal-title":"Endocr. J."},{"issue":"9","key":"10.1016\/j.colsurfb.2026.115842_bib10","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf4398","article-title":"Engineered ionizable lipid nanoparticles for targeted delivery of RNA therapeutics into different types of cells in the liver","volume":"7","author":"Kim","year":"2021","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115842_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics14010217","article-title":"Drug Targeting and Nanomedicine: Lessons Learned from Liver Targeting and Opportunities for Drug Innovation","volume":"14","author":"Salvati","year":"2022","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.colsurfb.2026.115842_bib12","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1146\/annurev.nutr.19.1.379","article-title":"Regulation of glucose production by the liver","volume":"19","author":"Nordlie","year":"1999","journal-title":"Annu. Rev. Nutr."},{"issue":"4","key":"10.1016\/j.colsurfb.2026.115842_bib13","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.jhep.2011.08.025","article-title":"The interaction of hepatic lipid and glucose metabolism in liver diseases","volume":"56","author":"Bechmann","year":"2012","journal-title":"J. Hepatol."},{"issue":"7","key":"10.1016\/j.colsurfb.2026.115842_bib14","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.tem.2017.03.003","article-title":"Unraveling the Regulation of Hepatic Metabolism by Insulin","volume":"28","author":"Titchenell","year":"2017","journal-title":"Trends Endocrinol. Metab. TEM"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115842_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/dom.12117","article-title":"Hepatoselectivity and the evolution of insulin","volume":"16","author":"Herring","year":"2014","journal-title":"Diabetes Obes. & Metab."},{"issue":"4","key":"10.1016\/j.colsurfb.2026.115842_bib16","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.cmet.2021.03.007","article-title":"Direct and indirect control of hepatic glucose production by insulin","volume":"33","author":"Lewis","year":"2021","journal-title":"Cell Metab."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115842_bib17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0168-8227(92)90030-U","article-title":"The effect of intraperitoneal insulin delivery on carbohydrate metabolism in type 1 (insulin-dependent) diabetic patients","volume":"15","author":"Monti","year":"1992","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.colsurfb.2026.115842_bib18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.jconrel.2023.12.045","article-title":"Recent advances in oral insulin delivery technologies","volume":"366","author":"Zhang","year":"2024","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"issue":"5","key":"10.1016\/j.colsurfb.2026.115842_bib19","doi-asserted-by":"crossref","first-page":"E891","DOI":"10.1152\/ajpendo.00628.2020","article-title":"Importance of the route of insulin delivery to its control of glucose metabolism","volume":"320","author":"Edgerton","year":"2021","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"9","key":"10.1016\/j.colsurfb.2026.115842_bib20","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.47391\/JPMA.11151","article-title":"Role of oral hypoglycaemic drugs in preventing complication in non-alcoholic fatty liver disease with type 2 diabetes mellitus","volume":"74","author":"Zahid","year":"2024","journal-title":"Jpma. J. Pak. Med. Assoc."},{"issue":"8","key":"10.1016\/j.colsurfb.2026.115842_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25084563","article-title":"Advances in the Pathogenesis of Diabetic Kidney Disease","volume":"25","author":"Kourtidou","year":"2024","journal-title":"Int J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115842_bib22","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s00289-007-0841-2","article-title":"Recent Development of Liver Targeted Drug Delivery System Based on Nanotechnology","volume":"26","author":"Wang","year":"2013","journal-title":"Polym. Bull."},{"issue":"9","key":"10.1016\/j.colsurfb.2026.115842_bib23","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1111\/dom.14761","article-title":"Reduced hypoglycaemia using liver-targeted insulin in individuals with type 1 diabetes","volume":"24","author":"W.R","year":"2022","journal-title":"Diabetes Obes. Metab."},{"issue":"4","key":"10.1016\/j.colsurfb.2026.115842_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1773","article-title":"microRNAs-based diagnostic and therapeutic applications in liver fibrosis","volume":"14","author":"Zhao","year":"2023","journal-title":"Wiley Interdiscip. Rev. RNA"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115842_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12951-023-01876-5","article-title":"Remodeling the hepatic fibrotic microenvironment with emerging nanotherapeutics: a comprehensive review","volume":"21","author":"Zhao","year":"2023","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.colsurfb.2026.115842_bib26","first-page":"1","article-title":"Liver structure, function, and anatomy: effects of hepatitis B virus","volume":"168","author":"Israel","year":"1991","journal-title":"Curr. Top. Microbiol. Immunol."},{"issue":"4","key":"10.1016\/j.colsurfb.2026.115842_bib27","first-page":"1751","article-title":"Liver Sinusoidal Endothelial Cells","volume":"5","author":"S\u00f8rensen","year":"2015"},{"issue":"6","key":"10.1016\/j.colsurfb.2026.115842_bib28","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1002\/hep.29706","article-title":"Gentle palpating liver sinusoidal endothelial cells reveals the dynamic behavior and formation of fenestrae: A new window for biomedical research","volume":"67","author":"Braet","year":"2018","journal-title":"Hepatol. (Baltim. Md. )"},{"issue":"5","key":"10.1016\/j.colsurfb.2026.115842_bib29","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s00292-020-00802-y","article-title":"[Liver sinusoids: pathology of endothelial findings]","volume":"41","author":"Goltz","year":"2020","journal-title":"Der Pathol."},{"key":"10.1016\/j.colsurfb.2026.115842_bib30","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.jconrel.2016.01.020","article-title":"Nanoparticle-liver interactions: Cellular uptake and hepatobiliary elimination","volume":"240","author":"Zhang","year":"2016","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"issue":"1-2","key":"10.1016\/j.colsurfb.2026.115842_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0378-5173(99)00447-0","article-title":"Biodistribution of fluoresceinated dextran using novel nanoparticles evading reticuloendothelial system","volume":"202","author":"Gaur","year":"2000","journal-title":"Int. J. Pharm."},{"issue":"5","key":"10.1016\/j.colsurfb.2026.115842_bib32","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.1021\/acsnano.9b01383","article-title":"Elimination Pathways of Nanoparticles","volume":"13","author":"Poon","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.colsurfb.2026.115842_bib33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jconrel.2014.07.037","article-title":"Stealth' lipid-based formulations: poly(ethylene glycol)-mediated digestion inhibition improves oral bioavailability of a model poorly water soluble drug","volume":"192","author":"Feeney","year":"2014","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"issue":"Pt A","key":"10.1016\/j.colsurfb.2026.115842_bib34","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115842_bib35","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1517\/17425247.2014.866651","article-title":"PEGylated nanomedicines: recent progress and remaining concerns","volume":"11","author":"Vllasaliu","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.colsurfb.2026.115842_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2024.172240","article-title":"Impact of physicochemical properties on biological effects of lipid nanoparticles: are they completely safe","volume":"927","author":"Yuan","year":"2024","journal-title":"Sci. Total Environ."},{"issue":"10","key":"10.1016\/j.colsurfb.2026.115842_bib37","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1021\/acs.molpharmaceut.4c00437","article-title":"Tumor-targeted CO nanodelivery system design and therapy for hepatocellular carcinoma","volume":"21","author":"Zhang","year":"2024","journal-title":"Mol. Pharm."},{"issue":"02","key":"10.1016\/j.colsurfb.2026.115842_bib38","first-page":"369","article-title":"Mechanisms of Targeted Drug Delivery for Liver Cancer: Active, Passive, and Subcellular Strategies","volume":"13","author":"Tian","year":"2025","journal-title":"J. Biosci. Med."},{"key":"10.1016\/j.colsurfb.2026.115842_bib39","article-title":"Navigating liver targeting: Fine-tuning chitosan nanocarriers through saccharide modification","volume":"95","author":"Kira","year":"2024","journal-title":"J. Drug Deliv. Sci. Technol."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115842_bib40","doi-asserted-by":"crossref","first-page":"6136","DOI":"10.1038\/s41467-024-50568-7","article-title":"Kupffer cells determine intrahepatic traffic of PEGylated liposomal doxorubicin","volume":"15","author":"Jiang","year":"2024","journal-title":"Nat. Commun."},{"issue":"20","key":"10.1016\/j.colsurfb.2026.115842_bib41","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1039\/D3TB02766J","article-title":"Lipid nanoparticles as the drug carrier for targeted therapy of hepatic disorders","volume":"12","author":"Chu","year":"2024","journal-title":"J. Mater. Chem. B"},{"key":"10.1016\/j.colsurfb.2026.115842_bib42","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.copbio.2020.07.006","article-title":"Engineering long-circulating nanomaterial delivery systems","volume":"66","author":"Fan","year":"2020","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.colsurfb.2026.115842_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113851","article-title":"Liposome composition in drug delivery design, synthesis, characterization, and clinical application","volume":"176","author":"Large","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"9","key":"10.1016\/j.colsurfb.2026.115842_bib44","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2337\/diacare.13.9.911","article-title":"Insulin Administration via Liposomes","volume":"13","author":"Spangler","year":"1990","journal-title":"Diabetes Care"},{"key":"10.1016\/j.colsurfb.2026.115842_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119457","article-title":"Liver-targeted Nano-MitoPBN normalizes glucose metabolism by improving mitochondrial redox balance","volume":"222","author":"Wu","year":"2019","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.colsurfb.2026.115842_bib46","article-title":"Investigation of FcRn-Mediated Transepithelial Mechanisms for Oral Nanoparticle Delivery Systems","volume":"4","author":"Yu","year":"2021","journal-title":"Adv. Ther."},{"key":"10.1016\/j.colsurfb.2026.115842_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2020.111203","article-title":"Folate targeted PEGylated liposomes for the oral delivery of insulin: In vitro and in vivo studies","volume":"194","author":"Yazdi","year":"2020","journal-title":"Colloids Surf. B Biointerfaces"},{"issue":"4","key":"10.1016\/j.colsurfb.2026.115842_bib48","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1021\/acs.bioconjchem.5c00037","article-title":"Fc Multisite Conjugation and Prolonged Delivery of the Folate-Targeted Drug Conjugate EC140","volume":"36","author":"Zheng","year":"2025","journal-title":"Bioconjugate Chem."},{"key":"10.1016\/j.colsurfb.2026.115842_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123870","article-title":"zwitterionic Pluronic analog-coated PLGA nanoparticles for oral insulin delivery","volume":"236","author":"Liu","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115842_bib50","article-title":"Recent advances in zwitterionic nanoscale drug delivery systems to overcome biological barriers","volume":"19","author":"Ouyang","year":"2024","journal-title":"Asian J. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2026.115842_bib51","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.jconrel.2015.12.008","article-title":"Efficient mucus permeation and tight junction opening by dissociable \"mucus-inert\" agent coated trimethyl chitosan nanoparticles for oral insulin delivery","volume":"222","author":"Liu","year":"2016","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"issue":"12","key":"10.1016\/j.colsurfb.2026.115842_bib52","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1038\/s41565-024-01764-5","article-title":"An orally administered glucose-responsive polymeric complex for high-efficiency and safe delivery of insulin in mice and pigs","volume":"19","author":"Ji","year":"2024","journal-title":"Nat. Nanotechnol."},{"issue":"13","key":"10.1016\/j.colsurfb.2026.115842_bib53","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201910168","article-title":"Liver\u2010Target and Glucose\u2010Responsive Polymersomes toward Mimicking Endogenous Insulin Secretion with Improved Hepatic Glucose Utilization","volume":"30","author":"Wang","year":"2020","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.colsurfb.2026.115842_bib54","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2025.161732","article-title":"Enterosoluble microcapsules embedded with tripeptide-modified zwitterionic nanosystems to overcome intestinal barriers for intact exocytosis and hepatic-targeted gradual insulin delivery","volume":"510","author":"Ma","year":"2025","journal-title":"Chem. Eng. J."},{"issue":"39","key":"10.1016\/j.colsurfb.2026.115842_bib55","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.ady6386","article-title":"Site-specific adaptive nanovesicles for oral insulin delivery","volume":"11","author":"Xia","year":"2025","journal-title":"Sci. Adv."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115842_bib56","doi-asserted-by":"crossref","DOI":"10.3390\/chemengineering9030056","article-title":"Liposome-Based Drug Delivery Systems: From Laboratory Research to Industrial Production\u2014Instruments and Challenges","volume":"9","author":"Basak","year":"2025","journal-title":"ChemEngineering"},{"key":"10.1016\/j.colsurfb.2026.115842_bib57","article-title":"Delivery Strategy to Enhance the Therapeutic Efficacy of Liver Fibrosis via Nanoparticle Drug Delivery Systems","author":"Liu","year":"2024","journal-title":"ACS nano"},{"issue":"21","key":"10.1016\/j.colsurfb.2026.115842_bib58","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.2174\/0929867330666230416153352","article-title":"Research Progress of Chitosan-based Multifunctional Nanoparticles in Cancer Targeted Therapy","volume":"31","author":"Lai","year":"2024","journal-title":"Curr. Med. Chem."},{"issue":"05","key":"10.1016\/j.colsurfb.2026.115842_bib59","first-page":"537","article-title":"Advances in asialoglycoprotein receptor-mediated liver cancer targeted drug delivery system","volume":"47","author":"Gao","year":"2016","journal-title":"J. China Pharm. Univ."},{"issue":"06","key":"10.1016\/j.colsurfb.2026.115842_bib60","first-page":"501","article-title":"Asialoglycoprotein Receptor and Its Application in Liver-targeted Drug Delivery","volume":"42","author":"Huang","year":"2015","journal-title":"Prog. Biochem. Biophys."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115842_bib61","doi-asserted-by":"crossref","first-page":"6649","DOI":"10.1038\/s41467-022-34357-8","article-title":"Ligand-switchable nanoparticles resembling viral surface for sequential drug delivery and improved oral insulin therapy","volume":"13","author":"Yang","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.colsurfb.2026.115842_bib62","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.carbpol.2018.04.052","article-title":"Enhanced delivery of doxorubicin to the liver through self-assembled nanoparticles formed via conjugation of glycyrrhetinic acid to the hydroxyl group of hyaluronic acid","volume":"195","author":"Wang","year":"2018","journal-title":"Carbohydr. Polym."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115842_bib63","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1007\/s13346-019-00618-1","article-title":"Inhibiting hepatic gluconeogenesis by chitosan lactate nanoparticles containing CRTC2 siRNA targeted by poly(ethylene glycol)-glycyrrhetinic acid","volume":"9","author":"Rastegari","year":"2019","journal-title":"Drug Deliv. Transl. Res."},{"issue":"6","key":"10.1016\/j.colsurfb.2026.115842_bib64","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.biomaterials.2007.10.026","article-title":"The use of deoxycholic acid to enhance the oral bioavailability of biodegradable nanoparticles","volume":"29","author":"Samstein","year":"2008","journal-title":"Biomaterials"},{"issue":"10","key":"10.1016\/j.colsurfb.2026.115842_bib65","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s11095-007-9289-1","article-title":"Bile acid transporters: structure, function, regulation and pathophysiological implications","volume":"24","author":"Alrefai","year":"2007","journal-title":"Pharm. Res."},{"issue":"Pt 10","key":"10.1016\/j.colsurfb.2026.115842_bib66","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1242\/jeb.204.10.1673","article-title":"Transport of bile acids in hepatic and non-hepatic tissues","volume":"204","author":"St-Pierre","year":"2001","journal-title":"J. Exp. Biol."},{"key":"10.1016\/j.colsurfb.2026.115842_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.steroids.2021.108879","article-title":"Research progress in the application of bile acid-drug conjugates: A \"trojan horse\" strategy","volume":"173","author":"Lei","year":"2021","journal-title":"Steroids"},{"issue":"8","key":"10.1016\/j.colsurfb.2026.115842_bib68","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.3390\/12081859","article-title":"Exploitation of bile acid transport systems in prodrug design","volume":"12","author":"Siev\u00e4nen","year":"2007","journal-title":"Mol. (Basel Switz. )"},{"issue":"1-2","key":"10.1016\/j.colsurfb.2026.115842_bib69","first-page":"86","article-title":"Structural requirements of bile acid transporters: C-3 and C-7 modifications of steroidal hydroxyl groups","volume":"46","author":"Kolhatkar","year":"2012","journal-title":"Eur. J. Pharm. Sci. Off. J. Eur. Fed. Pharm. Sci."},{"key":"10.1016\/j.colsurfb.2026.115842_bib70","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.biomaterials.2017.10.022","article-title":"Functional nanoparticles exploit the bile acid pathway to overcome multiple barriers of the intestinal epithelium for oral insulin delivery","volume":"151","author":"Fan","year":"2018","journal-title":"Biomaterials"},{"issue":"7","key":"10.1016\/j.colsurfb.2026.115842_bib71","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1021\/acs.molpharmaceut.6b00188","article-title":"Effective Enhancement of Hypoglycemic Effect of Insulin by Liver-Targeted Nanoparticles Containing Cholic Acid-Modified Chitosan Derivative","volume":"13","author":"Zhang","year":"2016","journal-title":"Mol. Pharm."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115842_bib72","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1080\/10717544.2018.1469685","article-title":"Liver-targeted delivery of insulin-loaded nanoparticles via enterohepatic circulation of bile acids","volume":"25","author":"Zhang","year":"2018","journal-title":"Drug Deliv."},{"issue":"31","key":"10.1016\/j.colsurfb.2026.115842_bib73","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.1039\/D1TB00806D","article-title":"Insulin- and cholic acid-loaded zein\/casein-dextran nanoparticles enhance the oral absorption and hypoglycemic effect of insulin","volume":"9","author":"Bao","year":"2021","journal-title":"J. Mater. Chem. B"},{"issue":"7","key":"10.1016\/j.colsurfb.2026.115842_bib74","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202302677","article-title":"Ursodeoxycholic Acid-Decorated Zwitterionic Nanoparticles for Orally Liver-Targeted Close-Looped Insulin Delivery","volume":"13","author":"Ma","year":"2024","journal-title":"Adv. Healthc. Mater."},{"key":"10.1016\/j.colsurfb.2026.115842_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.cej.2024.150129","article-title":"Oral delivery of berberine by liver-targeted zwitterionic nanoparticles to overcome multi-intestinal barriers and extend insulin treatment duration","volume":"485","author":"Ma","year":"2024","journal-title":"Chem. Eng. J."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115842_bib76","doi-asserted-by":"crossref","first-page":"4710","DOI":"10.1021\/acsnano.0c09278","article-title":"Quantum Dot Nanomedicine Formulations Dramatically Improve Pharmacological Properties and Alter Uptake Pathways of Metformin and Nicotinamide Mononucleotide in Aging Mice","volume":"15","author":"Hunt","year":"2021","journal-title":"ACS Nano"},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115842_bib77","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1021\/acsnano.9b06071","article-title":"Rapid Intestinal Uptake and Targeted Delivery to the Liver Endothelium Using Orally Administered Silver Sulfide Quantum Dots","volume":"14","author":"Hunt","year":"2020","journal-title":"ACS Nano"},{"issue":"4","key":"10.1016\/j.colsurfb.2026.115842_bib78","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41565-023-01565-2","article-title":"Oral nanotherapeutic formulation of insulin with reduced episodes of hypoglycaemia","volume":"19","author":"Hunt","year":"2024","journal-title":"Nat. Nanotechnol."},{"issue":"6","key":"10.1016\/j.colsurfb.2026.115842_bib79","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1177\/193229680900300627","article-title":"Hepatic-directed vesicle insulin: a review of formulation development and preclinical evaluation","volume":"3","author":"Geho","year":"2009","journal-title":"J. Diabetes Sci. Technol."},{"issue":"3","key":"10.1016\/j.colsurfb.2026.115842_bib80","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1177\/1932296814524871","article-title":"A single-blind, placebo-controlled, dose-ranging trial of oral hepatic-directed vesicle insulin add-on to oral antidiabetic treatment in patients with type 2 diabetes mellitus","volume":"8","author":"Geho","year":"2014","journal-title":"J. Diabetes Sci. Technol."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115842_bib81","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s12951-024-03062-7","article-title":"Critical updates on oral insulin drug delivery systems for type 2 diabetes mellitus","volume":"23","author":"Low","year":"2025","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.colsurfb.2026.115842_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2025.1661872","article-title":"Nanoparticle technologies for liver targeting and their applications in liver diseases","volume":"13","author":"Peng","year":"2025","journal-title":"Front. Bioeng. Biotechnol."},{"issue":"45","key":"10.1016\/j.colsurfb.2026.115842_bib83","doi-asserted-by":"crossref","first-page":"18789","DOI":"10.1039\/D4SC05606J","article-title":"Strategic design of GalNAc-helical peptide ligands for efficient liver targeting","volume":"15","author":"Ito","year":"2024","journal-title":"Chem. Sci."},{"issue":"10","key":"10.1016\/j.colsurfb.2026.115842_bib84","doi-asserted-by":"crossref","first-page":"2910","DOI":"10.1016\/j.ymthe.2021.06.002","article-title":"Ligand conjugate SAR and enhanced delivery in NHP","volume":"29","author":"Holland","year":"2021","journal-title":"Molecular therapy journal American Society Gene Therapy"},{"issue":"10","key":"10.1016\/j.colsurfb.2026.115842_bib85","doi-asserted-by":"crossref","first-page":"5423","DOI":"10.1093\/nar\/gkae350","article-title":"Evaluating the oral delivery of GalNAc-conjugated siRNAs in rodents and non-human primates","volume":"52","author":"Yu","year":"2024","journal-title":"Nucleic Acids Res."},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115842_bib86","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1134\/S1070428023020021","article-title":"Synthesis and Affinity of Novel Triantennary Ligands for the Asialoglycoprotein Receptor","volume":"59","author":"Petrov","year":"2023","journal-title":"Russ. J. Org. Chem."},{"key":"10.1016\/j.colsurfb.2026.115842_bib87","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.115130","article-title":"Nanocarriers transport across the gastrointestinal barriers: The contribution to oral bioavailability via blood circulation and lymphatic pathway","volume":"203","author":"Wang","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.colsurfb.2026.115842_bib88","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.smim.2017.10.001","article-title":"Formation of the Protein Corona: The Interface between Nanoparticles and the Immune System","volume":"34","author":"Barbero","year":"2017","journal-title":"Semin. Immunol."},{"key":"10.1016\/j.colsurfb.2026.115842_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.nano.2024.102774","article-title":"Size-dependent renal filtration model explains human pharmacokinetics of a functional nanoparticle: The SPAGOPIX-01 clinical trial","volume":"62","author":"Axelsson","year":"2024","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115842_bib90","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1021\/acs.analchem.7b04765","article-title":"Quantification of Nanomaterial\/Nanomedicine Trafficking in Vivo","volume":"90","author":"Wang","year":"2018","journal-title":"Anal. Chem."},{"key":"10.1016\/j.colsurfb.2026.115842_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.cis.2020.102261","article-title":"Absorption, distribution, metabolism, and excretion of nanocarriers in vivo and their influences","volume":"284","author":"Zhang","year":"2020","journal-title":"Adv. Colloid Interface Sci."},{"issue":"9","key":"10.1016\/j.colsurfb.2026.115842_bib92","doi-asserted-by":"crossref","first-page":"7805","DOI":"10.1021\/acsnano.5c20532","article-title":"Priming the Liver Endocytic Pathway to Accelerate Hepatobiliary Clearance of Nanoparticles","volume":"20","author":"Ren","year":"2026","journal-title":"ACS Nano"},{"issue":"8","key":"10.1016\/j.colsurfb.2026.115842_bib93","doi-asserted-by":"crossref","first-page":"9315","DOI":"10.1021\/acsnano.9b03942","article-title":"Pseudo-anaphylaxis to Polyethylene Glycol (PEG)-Coated Liposomes: Roles of Anti-PEG IgM and Complement Activation in a Porcine Model of Human Infusion Reactions","volume":"13","author":"Kozma","year":"2019","journal-title":"ACS Nano"},{"key":"10.1016\/j.colsurfb.2026.115842_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2022.175219","article-title":"Crosstalk between the liver and kidney in diabetic nephropathy","volume":"931","author":"Yang","year":"2022","journal-title":"Eur. J. Pharmacol."},{"issue":"4","key":"10.1016\/j.colsurfb.2026.115842_bib95","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/s41419-023-05792-2","article-title":"Genetic deletion of phosphodiesterase 4D in the liver improves kidney damage in high-fat fed mice: liver-kidney crosstalk","volume":"14","author":"Tao","year":"2023","journal-title":"Cell death & Dis."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115842_bib96","article-title":"CX08005, a Protein Tyrosine Phosphatase 1B Inhibitor, Attenuated Hepatic Lipid Accumulation and Microcirculation Dysfunction Associated with Nonalcoholic Fatty Liver Disease","volume":"16","author":"Li","year":"2023","journal-title":"Pharm. (Basel Switz. )"},{"issue":"7","key":"10.1016\/j.colsurfb.2026.115842_bib97","first-page":"70","article-title":"Adipose Tissue Dysfunction and Hepatic Steatosis in New-Onset Diabetes","volume":"6","author":"Rusu","year":"2025"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115842_bib98","doi-asserted-by":"crossref","first-page":"9","DOI":"10.5005\/jp-journals-10018-1288","article-title":"Nonalcoholic Fatty Liver Diseases among Recently Diagnosed Patients with Diabetes Mellitus and Risk Factors","volume":"9","author":"Butt","year":"2019","journal-title":"Eur. J. hepato-Gastroenterol."},{"issue":"Supplement_1","key":"10.1016\/j.colsurfb.2026.115842_bib99","doi-asserted-by":"crossref","DOI":"10.2337\/db21-999-P","article-title":"999-P: A Study to Assess Occurrence of NAFLD and Liver Fibrosis in Patients with T2DM and Associated Factors","volume":"70","author":"Nawal","year":"2021","journal-title":"Diabetes"},{"issue":"6","key":"10.1016\/j.colsurfb.2026.115842_bib100","article-title":"Changes in the proportion of regulatory T cell subpopulations during menstrual cycle and early pregnancy","volume":"88","author":"Okimura","year":"2022","journal-title":"American journal reproductive immunology (New York N. Y. 1989)"},{"issue":"4","key":"10.1016\/j.colsurfb.2026.115842_bib101","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/MAJ.0b013e31815adec8","article-title":"Catamenial diabetic ketoacidosis and catamenial hyperglycemia: case report and review of the literature","volume":"335","author":"Ovalle","year":"2008","journal-title":"Am. J. Med. Sci."},{"issue":"5","key":"10.1016\/j.colsurfb.2026.115842_bib102","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1002\/hep.31150","article-title":"Epidemiological Features of NAFLD From 1999 to 2018 in China","volume":"71","author":"Jianghua","year":"2020","journal-title":"Hepatol. (Baltim. Md. )"},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115842_bib103","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s13167-010-0010-9","article-title":"Diabetes mellitus: new challenges and innovative therapies","volume":"1","author":"Sena","year":"2010","journal-title":"EPMA J."},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115842_bib104","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00592-022-01978-w","article-title":"Metabolic-associated fatty liver disease increases the risk of end-stage renal disease in patients with biopsy-confirmed diabetic nephropathy: a propensity-matched cohort study","volume":"60","author":"Yutong","year":"2022","journal-title":"Acta Diabetol."},{"issue":"5","key":"10.1016\/j.colsurfb.2026.115842_bib105","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.kint.2022.06.013","article-title":"Executive summary of the KDIGO 2022 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease: an update based on rapidly emerging new evidence","volume":"102","author":"Rossing","year":"2022","journal-title":"Kidney Int."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115842_bib106","doi-asserted-by":"crossref","DOI":"10.1080\/10717544.2022.2160518","article-title":"Targeted drug delivery strategy: a bridge to the therapy of diabetic kidney disease","volume":"30","author":"Chen","year":"2023","journal-title":"Drug Deliv."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115842_bib107","first-page":"7","article-title":"Diabetic Nephropathy: Pathogenesis, Mechanisms, and Therapeutic Strategies","volume":"57","author":"Dwivedi","year":"2025","journal-title":"Horm. Metab. Res. = Horm. - und Stoffwechs. = Horm. Et. Metab."},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115842_bib108","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/03602532.2017.1293683","article-title":"Non-alcoholic fatty liver disease (NAFLD) - pathogenesis, classification, and effect on drug metabolizing enzymes and transporters","volume":"49","author":"Cobbina","year":"2017","journal-title":"Drug Metab. Rev."},{"issue":"4","key":"10.1016\/j.colsurfb.2026.115842_bib109","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.jhep.2020.01.013","article-title":"NAFLD as a driver of chronic kidney disease","volume":"72","author":"Byrne","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.colsurfb.2026.115842_bib110","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1032814","article-title":"Integrated analysis of potential gene crosstalk between non-alcoholic fatty liver disease and diabetic nephropathy","volume":"13","author":"Yan","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"5","key":"10.1016\/j.colsurfb.2026.115842_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/nu17050930","article-title":"Targeted Sodium Acetate Liposomes for Hepatocytes and Kupffer Cells: An Oral Dual-Targeted Therapeutic Approach for Non-Alcoholic Fatty Liver Disease Alleviation","volume":"17","author":"Hou","year":"2025","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.colsurfb.2026.115842_bib112","first-page":"1205","article-title":"Treatment of preestablished diet-induced fatty liver by oral fatty acid-bile acid conjugates in rodents","volume":"20","author":"Leikin-Frenkel","year":"2008","journal-title":"Eur. J. Gastroenterol. & Hepatol."},{"issue":"8","key":"10.1016\/j.colsurfb.2026.115842_bib113","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1089\/adt.2023.051","article-title":"Liver-Targeting Composite Nanocarrier Delivery System Based on Chitosan Nanoparticles and Phospholipid Complexes","volume":"21","author":"Kong","year":"2023","journal-title":"Assay. Drug Dev. Technol."},{"issue":"42","key":"10.1016\/j.colsurfb.2026.115842_bib114","doi-asserted-by":"crossref","first-page":"13764","DOI":"10.1021\/jacs.8b08014","article-title":"A Modular Ionophore Platform for Liver-Directed Copper Supplementation in Cells and Animals","volume":"140","author":"Su","year":"2018","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.colsurfb.2026.115842_bib115","article-title":"Nanotechnology in Drug Delivery for Liver Fibrosis","volume":"8","author":"Gu","year":"2021","journal-title":"Front. Mol. Biosci."},{"issue":"11","key":"10.1016\/j.colsurfb.2026.115842_bib116","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1038\/nmat4718","article-title":"Mechanism of hard-nanomaterial clearance by the liver","volume":"15","author":"Tsoi","year":"2016","journal-title":"Nat. Mater."},{"key":"10.1016\/j.colsurfb.2026.115842_bib117","unstructured":"Liyun Zhao, Study on Intervention effect of liver targetedmicelle encapsulate resveratrol in thenonalcoholic fatty liver, Hebei University of Engineering. (2018) ."},{"key":"10.1016\/j.colsurfb.2026.115842_bib118","first-page":"307139","article-title":"The hepatic-targeted, resveratrol loaded nanoparticles for relief of high fat diet-induced nonalcoholic fatty liver disease","author":"Teng","year":"2019","journal-title":"J. Control. Release"},{"issue":"5","key":"10.1016\/j.colsurfb.2026.115842_bib119","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202200468","article-title":"Hepatic-Targeted Nano-enzyme with Resveratrol Loading for Precise Relief of Nonalcoholic Steatohepatitis","volume":"18","author":"Tong","year":"2023","journal-title":"ChemMedChem"},{"issue":"15","key":"10.1016\/j.colsurfb.2026.115842_bib120","doi-asserted-by":"crossref","DOI":"10.3390\/ijms26157156","article-title":"Albumin Reduces Hepatic Steatosis and Inflammation in High-Fat-Diet-Fed Mice","volume":"26","author":"Rennie","year":"2025","journal-title":"Int J. Mol. Sci."},{"key":"10.1016\/j.colsurfb.2026.115842_bib121","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jconrel.2022.04.034","article-title":"Celastrol-loaded lactosylated albumin nanoparticles attenuate hepatic steatosis in non-alcoholic fatty liver disease","volume":"347","author":"Fan","year":"2022","journal-title":"J. Control. Release Off. J. Control. Release Soc."},{"key":"10.1016\/j.colsurfb.2026.115842_bib122","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2025.1729941","article-title":"Molecular mechanisms and multi-target therapeutic strategies of diabetic nephropathy: from pathogenesis to precision interventions","volume":"16","author":"Gong","year":"2025","journal-title":"Front Pharm."},{"key":"10.1016\/j.colsurfb.2026.115842_bib123","series-title":"Chronic Renal Disease","first-page":"863","article-title":"Liver Disease and Chronic Kidney Disease","author":"Neugarten","year":"2020"},{"issue":"10","key":"10.1016\/j.colsurfb.2026.115842_bib124","doi-asserted-by":"crossref","first-page":"9313","DOI":"10.1021\/acsnano.3c00875","article-title":"Biodegradable Hollow Nanoscavengers Restore Liver Functions to Reverse Insulin Resistance in Type 2 Diabetes","volume":"17","author":"Zhang","year":"2023","journal-title":"ACS Nano"},{"issue":"10","key":"10.1016\/j.colsurfb.2026.115842_bib125","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.colsurfb.2026.115842_bib126","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2023.123068","article-title":"Oral targeted delivery of Imatinib by pH responsive copolymer modulates liver fibrosis in the mice model","volume":"641","author":"Siapoush","year":"2023","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.colsurfb.2026.115842_bib127","doi-asserted-by":"crossref","DOI":"10.1016\/j.colsurfb.2024.114376","article-title":"Dual-ligand-functionalized nanostructured lipid carriers as a novel dehydrocavidine delivery system for liver fibrosis therapy","volume":"246","author":"Su","year":"2025","journal-title":"Colloids Surf. B. Biointerfaces"},{"issue":"2","key":"10.1016\/j.colsurfb.2026.115842_bib128","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/10837450.2024.2315460","article-title":"Oridonin loaded peptide nanovesicles alleviate nonalcoholic fatty liver disease in mice","volume":"29","author":"Zhang","year":"2024","journal-title":"Pharm. Dev. Technol."},{"issue":"1","key":"10.1016\/j.colsurfb.2026.115842_bib129","article-title":"Targeting hepatocytic T\u03b2RI ameliorates liver metastatic outcomes by revitalizing stem-like CD8(+) Tex subsets","volume":"16","author":"Wang","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.colsurfb.2026.115842_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.copbio.2024.103108","article-title":"Precise control methods of the physicochemical properties of nanoparticles for personalized medicine","volume":"87","author":"Nakamura","year":"2024","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.colsurfb.2026.115842_bib131","article-title":"Glucose-responsive nanozyme hydrogel for glycemic control and catalytic anti-infective therapy in diabetic wound healing","volume":"35","author":"Tai","year":"2025","journal-title":"Mater. Today Bio"},{"key":"10.1016\/j.colsurfb.2026.115842_bib132","doi-asserted-by":"crossref","DOI":"10.3389\/fgeed.2024.1458037","article-title":"In vivo liver targeted genome editing as therapeutic approach: progresses and challenges","volume":"6","author":"Simoni","year":"2024","journal-title":"Front. Genome Ed."},{"issue":"D1","key":"10.1016\/j.colsurfb.2026.115842_bib133","doi-asserted-by":"crossref","first-page":"D1670","DOI":"10.1093\/nar\/gkae973","article-title":"Generic Diagramming Platform (GDP): a comprehensive database of high-quality biomedical graphics","volume":"53","author":"Jiang","year":"2024","journal-title":"Nucleic Acids Res."}],"container-title":["Colloids and Surfaces B: Biointerfaces"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526004303?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0927776526004303?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T19:28:24Z","timestamp":1785785304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0927776526004303"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":133,"alternative-id":["S0927776526004303"],"URL":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.115842","relation":{},"ISSN":["0927-7765"],"issn-type":[{"value":"0927-7765","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral liver-targeted delivery systems for anti-hyperglycemic therapy: From passive to active targeting strategies","name":"articletitle","label":"Article Title"},{"value":"Colloids and Surfaces B: Biointerfaces","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.colsurfb.2026.115842","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"115842"}}